The Nrf2-ARE Pathway: A Valuable Therapeutic Target for the Treatment of Neurodegenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 2212-3954|7|3|218-229

ISSN： 1574-8898

Source： Recent Patents on CNS Drug Discovery, Vol.7, Iss.3, 2012-01, pp. : 218-229

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Role of the Keap1/Nrf2 pathway in neurodegenerative diseases

By  

PATHOLOGY INTERNATIONAL, Vol. 65, Iss. 5, 2015-05 ,pp. : 210-219

John Wiley & Sons Inc

Access to resources Recommend Favorite

Induction of Cytoprotective Genes Through Nrf2 / Antioxidant Response Element Pathway: A New Therapeutic Approach for the Treatment of Inflammatory Diseases

By  

Current Pharmaceutical Design, Vol. 10, Iss. 8, 2004-03 ,pp. : 879-891

Bentham Science Publishers

Access to resources Recommend Favorite

Phosphodiesterase as a New Therapeutic Target for the Treatment of Spinal Cord Injury and Neurodegenerative Diseases

By  

Current Medicinal Chemistry, Vol. 21, Iss. 24, 2014-08 ,pp. : 2830-2838

Bentham Science Publishers

Access to resources Recommend Favorite

Conformation as the Therapeutic Target for Neurodegenerative Diseases

By  

Current Alzheimer Research, Vol. 14, Iss. 4, 2017-02 ,pp. : 393-402

Bentham Science Publishers

Access to resources Recommend Favorite

The Nrf2-ARE Signalling Pathway: Promising Drug Target to Combat Oxidative Stress in Neurodegenerative Disorders

By  

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 3, 2005-06 ,pp. : 267-281

Bentham Science Publishers

Access to resources Recommend Favorite